Dark spots in your vision? Your eye vessels are already collapsing

A Blocked Retinal Artery Is Triaged Like a Stroke

The retina depends on a narrow set of vessels, and when blood stops reaching it, the tissue has little in reserve. That is why the professional guidance on sudden vision loss reads less like eye care and more like a stroke protocol.

The same circulation links three conditions usually discussed separately: an artery that blocks, a vein that clots, and small vessels in diabetes that close and give way to fragile ones that bleed.

The central retinal artery supplies the inner retina. The American Heart Association's 2021 scientific statement on central retinal artery occlusion describes the condition as compromised flow through that artery, which can cause retinal infarction, or tissue death. The statement calls it "a form of acute ischemic stroke" and says about 95% of cases result from thromboembolic disease: a clot or a fragment of plaque carried from elsewhere, such as the carotid artery or the heart.

The adjusted incidence in the United States is 1.9 per 100,000 person-years, rising with age, high blood pressure, high cholesterol, diabetes, tobacco use and obesity. The statement reports that fewer than 20% of affected patients regain functional vision in the affected eye.

The clock comes from animal work. Experiments in primates, summarized in a retina journal review, found the retina's tolerance to complete blockage to be no longer than about 240 minutes, with the best chance of full recovery when flow returned within about 97 minutes. The association's commentary notes that clot-dissolving studies borrow the 4.5-hour window used for stroke in the brain, and that painless vision loss in one eye "may go unnoticed for hours or even days."

Veins block as well. MedlinePlus, the national medical library's consumer service, says retinal vein occlusion is most often caused by hardening of the arteries, with diabetes, high blood pressure and glaucoma among the risk factors, and that it produces sudden blurring or loss of vision in all or part of one eye. A 2019 meta-analysis in a global health journal put prevalence at 0.77% of people aged 30 to 89 and found high blood pressure to be the strongest risk factor, with an odds ratio of 2.82. That is an observational association; it identifies who is at risk rather than proving a cause.

Diabetes works through the smallest vessels. Mayo Clinic's description is direct: "Damaged blood vessels close off, causing the growth of new, irregular blood vessels in the retina." That is the proliferative stage. The ophthalmology academy's patient guidance states that "these fragile new vessels often bleed into the vitreous," the space inside the eye, and that a small bleed can appear as a few dark floaters while a large one can block vision entirely.

The scale is large. A 2023 analysis in an ophthalmology journal estimated that 9.60 million Americans were living with diabetic retinopathy in 2021, about 26% of people with diabetes, and 1.84 million had a vision-threatening form. The early stages usually cause no symptoms, which is why the National Eye Institute recommends a dilated exam at least once a year for people with diabetes, and as often as every two to four months for some.

The academy's preferred practice pattern for retinal and ophthalmic artery occlusions, published in its journal in 2025, says an acute symptomatic blockage from an embolic source "should prompt an immediate referral to the nearest stroke referral center," along with a systemic evaluation for carotid and cardiac disease. In patients over 50, the same guidance says giant cell arteritis must also be suspected; that check typically includes blood tests for inflammation. The academy's clinical encyclopedia lists carotid ultrasound, echocardiography and heart-rhythm monitoring, and applies the same stroke-center referral to a brief loss of vision in one eye.

Practice has lagged the guidance. A study in an ophthalmology journal of 3,736 emergency visits for retinal artery blockage from 2016 to 2021 found testing rising each year, yet in the final year 57.87% of patients still received no stroke workup imaging.

For vein occlusions, the academy's guidance emphasizes control of blood pressure, diabetes and lipids, and communicating signs of organ damage to the primary care doctor. The eye is where the damage is seen; management usually happens elsewhere.